Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F F van Doormaal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|November 23, 2007
Development in anticoagulant therapyF F van Doormaal, H R Büller, S Middeldorp
The Netherlands Journal of Medicine|August 19, 2009
Cell-derived microvesicles and cancerF F van Doormaal, A Kleinjan, M Di Nisio, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Cancer and thrombosis: from molecular mechanisms to clinical presentationsH R Buller, F F van Doormaal, G L van Sluis, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2006
Intermittent mechanical compression for prevention of travellers' thrombosisM Coppens, F F van Doormaal, A J M Schreijer, et al.
The Netherlands Journal of Medicine|September 11, 2012
Limitations of screening for occult cancer in patients with idiopathic venous thromboembolismA Kleinjan, F F van Doormaal, M H Prins, et al.
The Netherlands Journal of Medicine|May 31, 2018
Classifying sepsis patients in the emergency department using SIRS, qSOFA or MEWSS W van der Woude, F F van Doormaal, B A Hutten, et al.
Thrombosis Research|December 9, 2008
Venous thrombo-embolism and aortic calcifications; more evidence on the link between venous and arterial thrombosisS Rafi, F F van Doormaal, K P van Lienden, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulationE A Akl, F F van Doormaal, M Barba, et al.
Journal of Thrombosis and Haemostasis : JTH|October 16, 2010
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?F F Van Doormaal, W Terpstra, R Van Der Griend, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|November 23, 2007
Development in anticoagulant therapyF F van Doormaal, H R Büller, S Middeldorp
The Netherlands Journal of Medicine|August 19, 2009
Cell-derived microvesicles and cancerF F van Doormaal, A Kleinjan, M Di Nisio, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Cancer and thrombosis: from molecular mechanisms to clinical presentationsH R Buller, F F van Doormaal, G L van Sluis, et al.
Journal of Thrombosis and Haemostasis : JTH|August 2, 2006
Intermittent mechanical compression for prevention of travellers' thrombosisM Coppens, F F van Doormaal, A J M Schreijer, et al.
The Netherlands Journal of Medicine|September 11, 2012
Limitations of screening for occult cancer in patients with idiopathic venous thromboembolismA Kleinjan, F F van Doormaal, M H Prins, et al.
The Netherlands Journal of Medicine|May 31, 2018
Classifying sepsis patients in the emergency department using SIRS, qSOFA or MEWSS W van der Woude, F F van Doormaal, B A Hutten, et al.
Thrombosis Research|December 9, 2008
Venous thrombo-embolism and aortic calcifications; more evidence on the link between venous and arterial thrombosisS Rafi, F F van Doormaal, K P van Lienden, et al.
The Cochrane Database of Systematic Reviews|July 20, 2007
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulationE A Akl, F F van Doormaal, M Barba, et al.
Journal of Thrombosis and Haemostasis : JTH|October 16, 2010
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?F F Van Doormaal, W Terpstra, R Van Der Griend, et al.
Pageof 1